Literature DB >> 25293868

Elevated plasma pigment epithelium-derived factor in children with type 2 diabetes mellitus is attributable to obesity.

Jeanie B Tryggestad1, Joshua J Wang2,3, Sarah X Zhang2,3, David M Thompson4, Kevin R Short1.   

Abstract

BACKGROUND: Pigment epithelium-derived factor (PEDF) is a member of the serpin family secreted by adipocytes. Plasma PEDF is increased in obese children and adults. Adults with type 2 diabetes mellitus (T2DM) have higher circulating PEDF but there are no reports in children with T2DM.
OBJECTIVE: To compare PEDF concentration in children with T2DM to normal weight and obese children without T2DM and determine associations with anthropometric or serum factors.
METHODS: Participants were 34 obese children with T2DM diagnosed by American Diabetes Association (ADA) criteria, 61 normal weight [body mass index (BMI) 25-75 percentile] and 63 obese (BMI ≥ 95 percentile) children of age 8-18 yr. Plasma PEDF was measured in fasting plasma samples. Anthropometric, serum, and body composition (dual-energy x-ray absorptiometry, DXA) data were obtained for each subject to identify potential predictor variables.
RESULTS: PEDF was 55% higher (p = 0.001) in the T2DM group compared with normal weight children, but did not differ from obese children. In the T2DM group, fat mass and lean mass both individually predicted PEDF (r² = 0.22 and 0.17, p = 0.02 and p < 0.01, respectively). PEDF was positively correlated with homeostatic model assessment - insulin resistance (HOMA-IR) when all groups were combined (r² = 0.15, p<0.001).
CONCLUSIONS: Plasma PEDF was similar in the T2DM and obese groups, therefore, obesity, rather than diabetes, may account for the higher PEDF in children with T2DM compared with normal weight children. PEDF was positively associated with both lean mass and fat mass both of which may contribute to the circulating level of the protein, and potentially to PEDF's association with insulin resistance in obese children with and without diabetes.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PEDF; T2DM; obesity

Mesh:

Substances:

Year:  2014        PMID: 25293868      PMCID: PMC8327465          DOI: 10.1111/pedi.12226

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  21 in total

1.  Augmented expression and secretion of adipose-derived pigment epithelium-derived factor does not alter local angiogenesis or contribute to the development of systemic metabolic derangements.

Authors:  Thomas V Lakeland; Melissa L Borg; Maria Matzaris; Amany Abdelkader; Roger G Evans; Matthew J Watt
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-22       Impact factor: 4.310

2.  Variations in the pattern of pubertal changes in boys.

Authors:  W A Marshall; J M Tanner
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

3.  Variations in pattern of pubertal changes in girls.

Authors:  W A Marshall; J M Tanner
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

4.  Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training.

Authors:  Frode Norheim; Truls Raastad; Bernd Thiede; Arild C Rustan; Christian A Drevon; Fred Haugen
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-09       Impact factor: 4.310

5.  Obese children have higher arterial elasticity without a difference in endothelial function: the role of body composition.

Authors:  Jeanie B Tryggestad; David M Thompson; Kenneth C Copeland; Kevin R Short
Journal:  Obesity (Silver Spring)       Date:  2011-10-13       Impact factor: 5.002

6.  Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension.

Authors:  Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Takanori Matsui; Yayoi Kurita; Tsutomu Imaizumi
Journal:  Int J Cardiol       Date:  2008-12-13       Impact factor: 4.164

7.  Arterial compliance is increased in children with type 2 diabetes compared with normal weight peers but not obese peers.

Authors:  Jeanie B Tryggestad; David M Thompson; Kenneth C Copeland; Kevin R Short
Journal:  Pediatr Diabetes       Date:  2013-03-05       Impact factor: 4.866

8.  Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.

Authors:  Kojiro Matsumoto; Hiroki Ishikawa; Daisuke Nishimura; Keisuke Hamasaki; Kazuhiko Nakao; Katsumi Eguchi
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients.

Authors:  Alicia Jenkins; Sarah X Zhang; Albina Gosmanova; Christopher Aston; Azar Dashti; Mary Zoe Baker; Timothy Lyons; Jian-Xing Ma
Journal:  Diabetes Res Clin Pract       Date:  2008-08-19       Impact factor: 5.602

10.  Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome.

Authors:  Sho-Ichi Yamagishi; Hisashi Adachi; Akio Abe; Takako Yashiro; Mika Enomoto; Kumiko Furuki; Asuka Hino; Yuko Jinnouchi; Katsuhiko Takenaka; Takanori Matsui; Kazuo Nakamura; Tsutomu Imaizumi
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

View more
  5 in total

Review 1.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

2.  Pigment Epithelium-Derived Factor Declines in Response to an Oral Glucose Load and Is Correlated with Vitamin D and BMI but Not Diabetes Status in Children and Young Adults.

Authors:  Allison C Sylvetsky; Najy T Issa; Avinash Chandran; Rebecca J Brown; Hussam J Alamri; Gabriella Aitcheson; Mary Walter; Kristina I Rother
Journal:  Horm Res Paediatr       Date:  2017-04-11       Impact factor: 2.852

3.  Emetine Di-HCl Attenuates Type 1 Diabetes Mellitus in Mice.

Authors:  LaQueta K Hudson; Meghan E Dancho; Jianhua Li; Johanna B Bruchfeld; Ahmed A Ragab; Mingzhu M He; Meaghan Bragg; Delaney Lenaghan; Michael D Quinn; Jason R Fritz; Matthew V Tanzi; Harold A Silverman; William M Hanes; Yaakov A Levine; Valentin A Pavlov; Peder S Olofsson; Jesse Roth; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Sangeeta S Chavan
Journal:  Mol Med       Date:  2016-06-10       Impact factor: 6.354

Review 4.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

Review 5.  Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis.

Authors:  Bing Yang; Liqing Lu; Dongmei Zhou; Wei Fan; Lucía Barbier-Torres; Justin Steggerda; Heping Yang; Xi Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.